Neuroimaging in patients with gliomas

Roland T Ullrich1, Lutz W Kracht, Andreas H Jacobs

  • 1Laboratory for Gene Therapy and Molecular Imaging, Max Planck Institute for Neurological Research with Klaus-Joachim-Zülch-Laboratories, Center for Molecular Medicine, University of Cologne, Gleuelerstrasse 50, Cologne, Germany.

Seminars in Neurology
|October 10, 2008
PubMed
Summary

Recent advances in multimodal molecular neuroimaging, combining magnetic resonance imaging (MRI) and positron emission tomography (PET), enhance the noninvasive assessment of primary brain tumors at the molecular level.

Related Concept Videos